Roy-Bz
CAS No. 1246304-91-5
Roy-Bz( PKCδ activator Roy-Bz )
Catalog No. M10997 CAS No. 1246304-91-5
Roy-Bz is the first small-molecule PKCδ-selective activator with EC50 of 58.5 nM, binds to the PKCδ-C1-domain.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameRoy-Bz
-
NoteResearch use only, not for human use.
-
Brief DescriptionRoy-Bz is the first small-molecule PKCδ-selective activator with EC50 of 58.5 nM, binds to the PKCδ-C1-domain.
-
DescriptionRoy-Bz is the first small-molecule PKCδ-selective activator with EC50 of 58.5 nM, binds to the PKCδ-C1-domain; displays no activity against human cPKCs (a mix of PKCα, β, and γ), nPKCδ, nPKCε and aPKCζ; potently inhibits the proliferation of colon cancer cells (HCT116 IC50=0.58 uM) by inducing a PKCδ-dependent mitochondrial apoptotic pathway involving caspase-3 activation; demonstrates PKCδ-dependent antitumor effect, through anti-proliferative, pro-apoptotic, and anti-angiogenic activities in xenograft mouse models with no apparent toxic side effects.
-
In Vitro——
-
In Vivo——
-
SynonymsPKCδ activator Roy-Bz
-
PathwayAngiogenesis
-
TargetPKC
-
RecptorPKC
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1246304-91-5
-
Formula Weight598.692
-
Molecular FormulaC36H38O8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(OC1=C(C(C)C)C(C([C@H](OC(C)=O)[C@@H](OC(C2=CC=CC=C2)=O)[C@@H](C(C)(C)CCC3)[C@@]43C)=C4C1=O)=O)C5=CC=CC=C5
-
Chemical Name(4bS,8aS,10S)-10-acetoxy-2-isopropyl-4b,8,8-trimethyl-1,4-dioxo-1,4,4b,5,6,7,8,8a,9,10-decahydrophenanthrene-3,9-diyl dibenzoate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bessa C, et al. Cell Death Dis. 2018 Jan 18;9(2):23.
molnova catalog
related products
-
Delcasertib
Delcasertib is a potent and selective inhibitor of δ-protein kinase C (δPKC).
-
DCPLA-ME
DCPLA-ME is the methyl ester form of DCPLA and can be used to treat neurodegenerative diseases. It is an effective PKCε activator.
-
PKC-theta inhibitor
PKC-theta inhibitor is PKC-θinhibitor with an?IC50?of 12 nM.
Cart
sales@molnova.com